CMS Proposes Major Increase in Reimbursement for Canaloplasty, page-414

We will be able to be much more confident about it after results are released later this month, but based on what we've seen so far I'd suggest any next raise would be an opportunistic one if the price is right (ie high above 50c). We obviously need to see the profit numbers first, but knowing these guys they're going to be trying to get to a profit fast. Since launch the bottom line has been consistently moving towards breakeven, so I could imagine that trend could continue (and in that case they should have more than enough cash to get them through to cash flow positive, and have the option to raise at a much higher price if the right opportunity presents itself). As mentioned yesterday as well, the most recent presentation actually hinted at a material improvement in the operating result